Full Length Research Paper
References
|
Abuhamdah S, Liping Huang, MSJE, Howes MJR, Ballard C, Holmes C, Burns, A, Perry EK, Lees PTFG, Chazot PL (2008). Pharmacological profile of an essential oil derived from Melissa officinalis with anti-agitation properties: focus on ligand-gated channels. J. Pharm. Pharmacol. 60:377-384. crossref |
||||
|
Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi A, Khani M (2003). Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial. J. Neurol. Neurosurg. Psychiatry 74:863-866. crossref |
||||
|
Allahverdiyev A, Duran N, Ozguven M, Koltas S (2004). Antiviral activity of the volatile oils of Melissa officinalis. Against Herpes simplex virus type-2. Phytomedicine 11:657-661. crossref |
||||
|
Awad R, Muhammad A, Durst T, Trudeau VL, Arnason JT (2009). Bioassay-guided Fractionation of Lemon Balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activity. Phytother. Res. 23(8):1075-1081. crossref |
||||
|
Baldwin DS, Ajel K (2007). Development and evaluation of psychotropic drugs. Psychiatry 6:279-283. crossref |
||||
| Bertolucci S, Lameira A, Pinto J (2008). Guia das plantas medicinais. In: Lameira, A. O.; Pinto, J. E. B. P., in: Belem (Ed.), Plantas medicinais: do cultivo, manipulacao e uso a recomendacao popular pp. 199-201. | ||||
| Birdane YEA (2007). Anti-inflamatory and nociceptive effects of Melissa officinalis L. in rodents. Rev. Med. Vet.158:75-81. | ||||
|
Bolkent S, Yanardag R, Karabulut-Bulan O, Yesilyaprak B (2005). Protective role of Melissa Officinalis L. extract on liver os hyperlipidemic rats: A morphological and biochemical study. J. Ethnopharmacol. 99:391-398. crossref |
||||
| Carvalho H, Cruz, F, Wiest, J (2005). Atividade antibacteriana em plantas com indicativo etnografico condimentar em Porto Alegre, RS/Brasil. Revista Brasileira de Plantas Medicinais Botucatu 7:25-32. | ||||
|
Carvalho NEA (2011). Evaluation of the genotoxic and antigenotoxic potential of Melissa officinalisinmice. Genet. Mol. Biol. 34:290-297. crossref |
||||
|
Cases J, Ibarra A, Feuillère N, Roller M, Sukkar SG (2011). Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Med. J. Nutr. Metab. 4:211-218. crossref |
||||
| Coimbra R (1994). Manual de Fitoterapia. 2nd edn. Editora Cejup, Belem, Brazil. | ||||
| Couto MEO (2006). Coleção de plantas medicinais, aromáticas e condimentares, Embrapa Clima Temperado. Documentos p 157. | ||||
| Dastmalchia K, Damien Dormana HJ, Oinonena PP, Darwisd Y, Laaksoa I, Hiltunena R (2008). Chemical composition and in vitro antioxidative activity of a lemon balm (Melissa officinalis L.) extract. Food Sci. Technol. 431:391-400. | ||||
|
Encalada MA, Hoyos KM, Rehecho S, Berasategi I, de Ciriano MG, Ansorena D, Astiasarán I, Navarro-Blasco I, Cavero RY, Calvo MI (2011). Anti-proliferative effect of Melissa officinalis on human colon cancer cell line. Plant Foods Hum. Nutr. 66:328-334. crossref |
||||
| Gerber DJ, Sotnikova TD, Gainetdinov RR, Huang YS, Caron MG, Susumu Tonegawa S (2001). Hiperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor deficient. Neurobiol. 98:15312-15317. | ||||
| Guginski G (2007). Análise da atividade farmacológica do extrato etanólico obtido da Melissa officinalis. Programa de pós-graduação em farmacologia Universidade federal de santa catarina. | ||||
| GurÄik Ľ, Dubravska R, MikloviÄova J (2005). Economics of the cultivation of Salvia officinalis and Melissa officinalis. Agricural Economics, West Lafayette 51:348-356. | ||||
|
Havsteen BH (2002). The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 96:67-202. crossref |
||||
|
Hodek P, Trefil P, Stiborova M (2002). Flavonoids-potent and versatile biologically active compounds interacting with cytocromes P450. Chem. Biol. Interact.139:1-21. crossref |
||||
|
Ibarra A, Feuillere N, Roller M, Lesburgere E, Beracochea D (2010). Effects of chronic administration of Melissa officinalis L. extract on anxiety-like reactivity and on circadian and exploratory activities in mice. Phytomedicine 17:397-403. crossref |
||||
|
Kamdem JP, Adeniran A, Boligon AA, Klimaczewski CV, Elekofehinti OO, Hassan W, Ibrahim M, Waczuk EP, Meinerz DF, Athayde ML (2013). Antioxidant activity, genotoxicity and cytotoxicity evaluation of lemon balm (Melissa officinalis L.) ethanolic extract: Its potential role in neuroprotection. Ind. Crops Prod.51:26-34 crossref |
||||
|
Kennedy D (2006). Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytother. Res. 20:96-102. crossref |
||||
|
Kennedy DW, Scholey AB (2004). Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosom. Med. 66:607-613. crossref |
||||
|
Kennedy DO, Scholey AB, Tildesley NT, Perry EK, Wesnes KA (2002). Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon Balm). Pharmacol. Biochem. Behav.72:953-964. crossref |
||||
|
Lewis DA, Cho RY, Carter CS, Eklund K, Forster S, Kelly MA, Montrose D (2008). Subunit selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. Am. J. Psychiatry 165:1585-1593. crossref |
||||
|
López VC, MartıS, Go´mez-Serranillos MP, Carretero, ME Ja¨ger, AK, Calvo MI (2009). Neuroprotective and Neurological Properties of Melissa officinalis. Neurochem. Res. 34. crossref |
||||
| Lorenzi H, Matos F (2002). Plantas medicinais no Brasil: nativas e exóticas. | ||||
|
May G, Willuhn G (1978). Antiviral effect of aqueous plant extracts in tissue culture [in German; English abstract]. Arzneimittelforschung 28:1-7. Pubmed |
||||
|
Menzies L, Ooi C, Kamath S, Suckling J, Mc Kenna P, Fletcher P, Bullmore E, Stephenson C (2007). Effects of gamma-aminobutyric acid modulating drugs on working memory and brain fucntion in patients with schizophrenia. Arch. Gen. Psychiatry 64:156-167. crossref |
||||
|
Millan M (2003). The neurobiology and control of anxious states. Prog. Neurobiol.70:83-244. crossref |
||||
| Moradkhani H, Sargsyan E, Bibak H, Naseri B, Sadat-Hosseini M, Fayazi-Barjin A, Meftahizade H (2010). Melissa officinalis L., a valuable medicine plant: A review. J. Med. Plants Res. 4:2753-2759. | ||||
| Moura LC (2006). Fitoterapia aplicada em Farmácias: Estudo dos Fitoterápicos Ansiolíticos, Sedativos e Antidepressivos, Farmácia. Escola de Saúde Pública do Ceará., Especialização em assistência farmacêutica. | ||||
| Müzell DP (2006). Preopriedades Biológicas de Extratos de Melissa officinalis L. (Lamiaceae) em Ratos Wistar, Biociências. PUC-RS. Especialização em Biologia Molecular. | ||||
|
Nakazawa T, Ohsawa K (1998). Metabolism of Rosmarinic Acid in Rats. J. Nat. Prod. 61:993-996. crossref |
||||
|
Pereira RP, Fachinetto R, de Souza Prestes A, Puntel RL, Santos da Silva GN, Heinzmann BM, Boschetti TK, Athayde ML, Bürger ME, Morel AF, Morsch VM, Rocha JB (2009). Antioxidant effects of different extracts from Melissa officinalis, Matricariarecutita and Cymbopogoncitratus. Neurochem. Res.34:973-983. crossref |
||||
|
Pereira P, Tysca D, Oliveira P, Brum LFS, Picada JN, Ardenghi (2005). Neurobehavioral and genotoxic aspects of rosmarinic acid. Pharmacol. Res. 52:199-203. crossref |
||||
|
Petersen M, Simmonds MSJ (2003). Rosmarinic acid. Phytochemistry 62:121-25. crossref |
||||
|
Radley JJ, Gosselin KL, Sawchenko PE (2009). A discrete GABAergic-relay mediates medial prefrontal cortical inhibition of the neuroendocrine stress response. J. Neurosci. 29:7330-7340. crossref |
||||
|
Ribeiro M, Bernardo-gil MG (2001). Melissa officinalis, L.: study of antioxidant activity in supercritical residues. J. Supercrit. Fluids 21:51-60. crossref |
||||
|
Saraydin SU, Tuncer E, Tepe B, Karadayi S, Özer H, Åžen M, Karadayi K, Inan D, Elagöz Åž, Polat Z, Duman M, Turan M (2012). Antitumoral effects of Melissa officinalis on breast cancer in vitro and in vivo. Asian Pac. J. Cancer Prev.13:2765-2770. crossref |
||||
|
Schemann M, Michel K, Zeller F, Hohenester B, Rühl A (2006). Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum. Phytomedicine 13:90-99. crossref |
||||
|
Schnitzler P, Schuhmacher A, Astani A, Reichling J (2008). Melissa officinalis oil affects infectivity of enveloped herpes viruses. Phytomedicine 15 :734-740. crossref |
||||
|
Simmen U, Kelber O, Okpaneji SN, Jaeggi R, Buetler B, Weiser D (2006). Binding of STW 5 (Iberogast) and its components to intestinal 5-HT, muscarinic M3 and opioid receptors. Phytomedicine 13:51-55. crossref |
||||
|
Sinclair L, Nutt D (2007). Anxiolytics. Psychiatry 6:284-288. crossref |
||||
|
Sorensen J (2000). Melissa officinalis – essential oil – authenticity, production and pharmacological activity – a review. Int. J. Aromather.10:7-15. crossref |
||||
|
Svobodová A, Psotová J, Walterová D (2003). Natural phenolics in the prevention of UV-induced skin damage. A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 147(2):137-145. crossref |
||||
| Taiwo A (2007). Alterações Comportamentais decorrentes da administração de Mellissa officinali sem ratos, Faculdade de Ciência da Saúde. Universidade de Brasília. | ||||
|
Thoeringer C, Erhardt A, Sillaber I, Mueller M, Ohl F, Holsboer F, Keck M (2009). Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6mice. J. Psychopharmacol. 24:733-743. crossref |
||||
|
Wake G, Court J, Pickering A, Lewis R, Wilkins R, Perry E (2000). CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. J. Ethnopharmacol. 69:105-114. crossref |
||||
| Wanderer M (2004). Produção de mudas e rendimento de biomassa de melissa (Melissa officinalis L.) sob diferentes espaçamentos de plantas e cobertura de solos., Mestrado em Fitotecnia. Universidade Federal do Rio Grande do Sul. p 122. | ||||
| Wecker L, Catalano G (2006). Tratamento da ansiedade e dos distúrbios do sono: In: Brody Farmacologia Humana. Elsevier 285-286. | ||||
| Weeks BS (2009). Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action. Relarian. Med. Sci. Monit. 15:256-262. | ||||
| WHO (2002). Monographs on selected medicinal plants. WHO Graphics 2, 351. | ||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
